Morningstar Korea Appoints Andy Jung, CFA, as Director of Manager Research

公司 每日财经网

HONG KONG, Jan. 5, 2015—MorningstarKorea, Ltd., a subsidiary of leading independent investment research provider Morningstar, Inc. (NASDAQ: MORN), today announced that Andy (Seung-Hye) Jung, CFA,has joined the company as director of manager research. Jung oversees Morningstar Korea’s qualitative and quantitative manager research in the country.

Jung is responsible for leading four manager research analysts and directingMorningstar’s coverage of the Korean market, which includes analyst reports, articles, and white papers about investment funds, asset managers, and relevant topics for Korean investors. Jung is based in Seoul and reports jointly to Grant Kennaway, Morningstar’s head of Asia-Pacific manager research, andJung-Tae Chae, chief executive officer of Morningstar Korea.

“We’re thrilled to welcome Andy to Morningstar Korea. We began offering qualitative fund ratings and research reports in Asia about five years ago, to help investors make more informed investing decisions,” Chae said. “Andyhas extensive knowledge of the Korean asset management industry, with experience in manager research and fund and product evaluation, and will add valuable insights to our research effort.“

Jungwas previously an asset manager for Woori Bank’s Retirement Pension department, where she conducted manager selection, performance monitoring, portfolio construction, and retirement pension product development. She previously worked as a senior investment consultant for Towers Watson and as a research and competitive analysis manager for Fidelity Asset Management Limited. From 2000 to 2003, Jung was a deputy manager on the research team for the joint venture of Morningstar, Inc. and Shinheung Securities in Korea.

Jung holds a bachelor’s degree in psychology and a master’s degree in international studies from Chung-Ang University in Seoul. She also holds the Chartered Financial Analyst® (CFA) designation and is currently a member of the CFA Korea Society’s education committee. She previously served as a member of the society’s career development and GIPS committees.

Morningstar has approximately 100 manager research analysts worldwide who cover approximately 4,300 funds. The company provides data on approximately 175,000 open-end mutual funds, 9,700 closed-end funds, and 11,000 exchange-traded product listings as of Sept. 30, 2014.

About Morningstar Korea, Ltd. and Morningstar, Inc.
Morningstar Korea, Ltd. is a subsidiary of Morningstar, Inc., a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offers an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors. Morningstar provides data on approximately 479,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 13 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately USD$169 billion in assets under advisement and management as of Sept. 30, 2014. The company has operations in 27 countries.

Morningstar expanded to Asia in April 2000 and has grown its businesses into Japan, Korea, India, mainland China, Taiwan, Singapore, and Hong Kong. The Asia operations not only offer timely information on mutual funds, but also insightful and independent analyses, unbiased fund ratings, and sophisticated analytical tools to help both individual and professional investors make better investment decisions.

# # #

©2015 Morningstar, Inc. All rights reserved.


MORN-C

Media Contacts:

In Korea: Jung-Tae Chae, +82237710701 or jungtae.chae@morningstar.com

In Hong Kong: Cecilica Chung, +85229734655 or cecilica.chung@morningstar.com

✽本文资讯仅供参考,并不构成投资或采购等决策建议(BW)。

HONG KONG/SINGAPORE, 26August 2015—Morningstar, Inc. (NASDAQ: MORN), a leading provider of independent investment
  • 公司
  • 2015-8-26
  • 每日财经网
國際獨立投資研究機構Morningstar, Inc.(NASDAQ: MORN)旗下Morningstar亞洲今日公佈最新環球基金投資者體驗研究報告(Global Fund Investor Experience Report),研究投資
  • 公司
  • 2015-6-9
  • 每日财经网
香港,2015年3月26日-國際獨立投資研究機構Morningstar, Inc.(NASDAQ:MORN)今天發表了第三份年度環球流量報告,回顧2014年全球互惠基金及交易所買賣產品(ETP)的資產流量。
  • 公司
  • 2015-3-26
  • 每日财经网
香港,2015年3月13日 – 国际独立投资研究机构Morningstar, Inc.(NASDAQ: MORN)旗下晨星投资管理(亚洲)有限公司今日公布最佳基金及最佳基金公司奖2015得奖名单。
  • 公司
  • 2015-3-13
  • 每日财经网
ANZUPGO(迪高替尼)乳膏现已成为FDA批准的美国首个且唯一的专用于治疗成人中重度慢性手部湿疹(CHE)的药物。1 全世界大约十分之一的成年人受到CHE的困扰,但在此之前,FDA尚未批准针对此类疾病患者的特定治疗药物。2,3 本次获批标…
大模型领域前一阵有个刷屏新闻,现代知名音乐制作人Rick Rubin和Anthropic合作,对《道德经》做了个二创,通过改编老子的原文,写了部《编码之道》(The Way of Code),对AI编码这种新开发方式做了一次哲学诠释,受到社…
  • 科技
  • 4天前
  • 每日财经网
1Globe领导的激进董事会为误导股东的判断公然歪曲纽约法院的裁定,并蓄意隐瞒安提瓜法官上周五拒绝了其立即阻止Prime Success行使投票权的企图 香港--(美国商业资讯)-- Prime Success L.P.(连同其关联方,合称…
  • 公司
  • 6月23日
  • 文传商讯
纽约法院驳回尚珹资本/Prime 紧急禁令救济申请 为股息支付代理公司于2025年7月7日发放每股55.00美元特别现金股息扫清法律障碍 北京--(美国商业资讯)--中国领先的生物制药公司科兴控股生物技术有限公司(Sinovac Biote…
  • 公司
  • 6月23日
  • 文传商讯
—FDA批准的首个用于阿尔茨海默病患者评估的血液体外诊断检测方法— —推出精准、便捷的血液诊断检测将有助于开发和提供更有效的阿尔茨海默病干预措施— 宾夕法尼亚州马尔文和东京--(美国商业资讯)-- Fujirebio今日宣布,该公司的Lum…
  • 公司
  • 5月19日
  • 文传商讯